감각이상 치료 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2034년)
Paresthesia Treatment Market (Type: Acute Paresthesia and Chronic Paresthesia; and Indication: Radiculopathy and Neuropathy) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
상품코드:1552779
리서치사:Transparency Market Research
발행일:2024년 07월
페이지 정보:영문 154 Pages
라이선스 & 가격 (부가세 별도)
한글목차
감각이상 치료 시장 - 조사 범위
TMR의 조사 보고서 "세계 감각이상 치료 시장"은 2024년부터 2034년까지의 예측 기간 동안 시장 지표에 대한 귀중한 인사이트를 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회를 조사하고 있습니다. 이 보고서는 2024년을 기준 연도로, 2034년을 예측연도로 하여 2018년부터 2034년까지의 세계 감각이상 치료 시장의 수익과 예측을 제공합니다. 또한 2024년부터 2034년까지 세계 감각이상 치료 시장의 복합 연간 성장률(CAGR %)도 제시합니다.
이 보고서는 광범위한 조사를 통해 작성되었습니다. 1차 조사에서 애널리스트는 주요 오피니언 리더, 업계 리더, 오피니언 메이커를 대상으로 인터뷰를 진행했습니다. 2차 조사에서는 주요 기업의 제품 자료, 연례 보고서, 보도 자료, 관련 자료 등을 참고하여 감각이상 치료 시장을 이해하고자 했습니다.
시장 스냅샷
2023년 시장 규모
54억 달러
2034년 시장 규모
80억 달러
CAGR
3.7%
이 보고서는 세계 감각이상 치료 시장의 경쟁 환경을 조사하고 있습니다. 세계 감각이상 치료 시장에서 사업을 운영하는 주요 기업들이 확인되었으며, 각 기업들은 다양한 속성으로 프로파일링되었습니다. 회사 개요, 재무 상태, 최근 동향, SWOT 등은 이 보고서에서 소개하는 세계 감각이상 치료 시장 기업의 속성입니다.
목차
제1장 서문
제2장 가정과 조사 방법
제3장 주요 요약 : 세계 시장
제4장 시장 개요
소개
개요
시장 역학
세계의 시장 분석과 예측, 2020-2034년
제5장 주요 인사이트
파이프라인 분석
주요 제품/브랜드 분석
주요 M&A
COVID-19에 의한 산업에 대한 영향
제6장 세계의 시장 분석과 예측 : 유형별
소개와 정의
주요 조사 결과·발전
시장 금액 예측 : 유형별, 2020-2034년
급성 감각이상
만성 감각이상
시장 매력 : 유형별
제7장 세계의 시장 분석과 예측 : 치료별
소개와 정의
주요 조사 결과·발전
시장 금액 예측 : 치료별, 2020-2034년
면역억제제
항경련제
외용 크림
항바이러스제
시장 매력 : 치료별
제8장 세계의 시장 분석과 예측 : 적응증별
소개와 정의
주요 조사 결과·발전
시장 금액 예측 : 적응증별, 2020-2034년
신경근장애
신경장애
시장 매력 : 적응증별
제9장 세계의 시장 분석과 예측 : 최종사용자별
소개와 정의
주요 조사 결과·발전
시장 금액 예측 : 최종사용자별, 2020-2034년
병원 약국
소매 약국
온라인 약국
시장 매력 : 최종사용자별
제10장 세계의 시장 분석과 예측 : 지역별
주요 조사 결과
시장 금액 예측 : 지역별, 2020-2034년
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
시장 매력 : 지역별
제11장 북미의 시장 분석과 예측
제12장 유럽의 시장 분석과 예측
제13장 아시아태평양의 시장 분석과 예측
제14장 라틴아메리카의 시장 분석과 예측
제15장 중동 및 아프리카의 시장 분석과 예측
제16장 경쟁 상황
시장 기업 - 경쟁 매트릭스(기업 계층과 규모별)
시장 점유율 분석 : 기업별(2023)
기업 개요
Pfizer Inc.
Novartis AG
GSK PLC
Merck & Co., Inc.
Johnson & Johnson
Teva Pharmaceutical Industries Ltd.
AbbVie Inc.
Amgen Inc.
AstraZeneca plc
Bayer AG
Eli Lilly & Co.
Sanofi S.A.
ksm
영문 목차
영문목차
Paresthesia Treatment Market - Scope of Report
TMR's report on the global paresthesia treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global paresthesia treatment market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global paresthesia treatment market from 2024 to 2034.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the paresthesia treatment market.
Market Snapshot
Market Value in 2023
US$ 5.4 Bn
Market Value in 2034
US$ 8 Bn
CAGR
3.7%
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global paresthesia treatment market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global paresthesia treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global paresthesia treatment market.
The report delves into the competitive landscape of the global paresthesia treatment market. Key players operating in the global paresthesia treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global paresthesia treatment market profiled in this report.
Key Questions Answered in Global paresthesia treatment Market Report:
What is the sales/revenue generated by paresthesia treatment across all regions during the forecast period?
What are the opportunities in the global paresthesia treatment market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2034?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Paresthesia Treatment Market - Research Objectives and Research Approach
The comprehensive report on the global paresthesia treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global paresthesia treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global paresthesia treatment market.
Table of Contents
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Paresthesia Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Paresthesia Treatment Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Paresthesia Treatment Market Analysis and Forecast, by Type
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type, 2020-2034
6.3.1. Acute Paresthesia
6.3.2. Chronic Paresthesia
6.4. Market Attractiveness, by Type
7. Global Paresthesia Treatment Market Analysis and Forecast, by Treatment
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Treatment, 2020-2034
7.3.1. Immunosuppressants
7.3.2. Anticonvulsants
7.3.3. Topical Creams
7.3.4. Antivirals
7.4. Market Attractiveness, by Treatment
8. Global Paresthesia Treatment Market Analysis and Forecast, by Indication
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Indication, 2020-2034
8.3.1. Radiculopathy
8.3.2. Neuropathy
8.4. Market Attractiveness, by Indication
9. Global Paresthesia Treatment Market Analysis and Forecast, by End-user
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2020-2034
9.3.1. Hospital Pharmacies
9.3.2. Retail Pharmacies
9.3.3. Online Pharmacies
9.4. Market Attractiveness, by End-user
10. Global Paresthesia Treatment Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2020-2034
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
11. North America Paresthesia Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Type, 2020-2034
11.2.1. Acute Paresthesia
11.2.2. Chronic Paresthesia
11.3. Market Attractiveness, by Type
11.4. Market Value Forecast, by Treatment, 2020-2034
11.4.1. Immunosuppressants
11.4.2. Anticonvulsants
11.4.3. Topical Creams
11.4.4. Antivirals
11.5. Market Attractiveness, by Treatment
11.6. Market Value Forecast, by Indication, 2020-2034
11.6.1. Radiculopathy
11.6.2. Neuropathy
11.7. Market Attractiveness, by Indication
11.8. Market Value Forecast, by End-user, 2020-2034
11.8.1. Hospital Pharmacies
11.8.2. Retail Pharmacies
11.8.3. Online Pharmacies
11.9. Market Attractiveness, by End-user
11.10. Market Value Forecast, by Country/Sub-region, 2020-2034
11.10.1. U.S.
11.10.2. Canada
11.11. Market Attractiveness Analysis
11.11.1. By Type
11.11.2. By Treatment
11.11.3. By Indication
11.11.4. By End-user
11.11.5. By Country
12. Europe Paresthesia Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2020-2034
12.2.1. Acute Paresthesia
12.2.2. Chronic Paresthesia
12.3. Market Attractiveness, by Type
12.4. Market Value Forecast, by Treatment, 2020-2034
12.4.1. Immunosuppressants
12.4.2. Anticonvulsants
12.4.3. Topical Creams
12.4.4. Antivirals
12.5. Market Attractiveness, by Treatment
12.6. Market Value Forecast, by Indication, 2020-2034
12.6.1. Radiculopathy
12.6.2. Neuropathy
12.7. Market Attractiveness, by Indication
12.8. Market Value Forecast, by End-user, 2020-2034
12.8.1. Hospital Pharmacies
12.8.2. Retail Pharmacies
12.8.3. Online Pharmacies
12.9. Market Attractiveness, by End-user
12.10. Market Value Forecast, by Country/Sub-region, 2020-2034
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
12.11.1. By Type
12.11.2. By Treatment
12.11.3. By Indication
12.11.4. By End-user
12.11.5. By Country/Sub-region
13. Asia Pacific Paresthesia Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type, 2020-2034
13.2.1. Acute Paresthesia
13.2.2. Chronic Paresthesia
13.3. Market Attractiveness, by Type
13.4. Market Value Forecast, by Treatment, 2020-2034
13.4.1. Immunosuppressants
13.4.2. Anticonvulsants
13.4.3. Topical Creams
13.4.4. Antivirals
13.5. Market Attractiveness, by Treatment
13.6. Market Value Forecast, by Indication, 2020-2034
13.6.1. Radiculopathy
13.6.2. Neuropathy
13.7. Market Attractiveness, by Indication
13.8. Market Value Forecast, by End-user, 2020-2034
13.8.1. Hospital Pharmacies
13.8.2. Retail Pharmacies
13.8.3. Online Pharmacies
13.9. Market Attractiveness, by End-user
13.10. Market Value Forecast, by Country/Sub-region, 2020-2034
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
13.11.1. By Type
13.11.2. By Treatment
13.11.3. By Indication
13.11.4. By End-user
13.11.5. By Country/Sub-region
14. Latin America Paresthesia Treatment Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Type, 2020-2034
14.2.1. Acute Paresthesia
14.2.2. Chronic Paresthesia
14.3. Market Attractiveness, by Type
14.4. Market Value Forecast, by Treatment, 2020-2034
14.4.1. Immunosuppressants
14.4.2. Anticonvulsants
14.4.3. Topical Creams
14.4.4. Antivirals
14.5. Market Attractiveness, by Treatment
14.6. Market Value Forecast, by Indication, 2020-2034
14.6.1. Radiculopathy
14.6.2. Neuropathy
14.7. Market Attractiveness, by Indication
14.8. Market Value Forecast, by End-user, 2020-2034
14.8.1. Hospital Pharmacies
14.8.2. Retail Pharmacies
14.8.3. Online Pharmacies
14.9. Market Attractiveness, by End-user
14.10. Market Value Forecast, by Country/Sub-region, 2020-2034
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
14.11.1. By Type
14.11.2. By Treatment
14.11.3. By Indication
14.11.4. By End-user
14.11.5. By Country/Sub-region
15. Middle East & Africa Paresthesia Treatment Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Type, 2020-2034
15.2.1. Acute Paresthesia
15.2.2. Chronic Paresthesia
15.3. Market Attractiveness, by Type
15.4. Market Value Forecast, by Treatment, 2020-2034
15.4.1. Immunosuppressants
15.4.2. Anticonvulsants
15.4.3. Topical Creams
15.4.4. Antivirals
15.5. Market Attractiveness, by Treatment
15.6. Market Value Forecast, by Indication, 2020-2034
15.6.1. Radiculopathy
15.6.2. Neuropathy
15.7. Market Attractiveness, by Indication
15.8. Market Value Forecast, by End-user, 2020-2034
15.8.1. Hospital Pharmacies
15.8.2. Retail Pharmacies
15.8.3. Online Pharmacies
15.9. Market Attractiveness, by End-user
15.10. Market Value Forecast, by Country/Sub-region, 2020-2034
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
15.11.1. By Type
15.11.2. By Treatment
15.11.3. By Indication
15.11.4. By End-user
15.11.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2023)
16.3. Company Profiles
16.3.1. Pfizer Inc.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Novartis AG
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. GSK PLC
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Merck & Co., Inc.
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Johnson & Johnson
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Teva Pharmaceutical Industries Ltd.
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. AbbVie Inc.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Amgen Inc.
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. AstraZeneca plc
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Bayer AG
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
16.3.11. Eli Lilly & Co.
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Product Portfolio
16.3.11.3. Financial Overview
16.3.11.4. SWOT Analysis
16.3.11.5. Strategic Overview
16.3.12. Sanofi S.A.
16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
